Andreas Bunge
About
In The Last Decade
Andreas Bunge
15 papers receiving 467 citations
Peers
Comparison fields: 5 of 65
- Molecular Biology 415
- Biomedical Engineering 57
- Oncology 53
- Organic Chemistry 50
- Biomaterials 39
Countries citing papers authored by Andreas Bunge
This map shows the geographic impact of Andreas Bunge's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Andreas Bunge with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Andreas Bunge more than expected).
Fields of papers citing papers by Andreas Bunge
This network shows the impact of papers produced by Andreas Bunge. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Andreas Bunge. The network helps show where Andreas Bunge may publish in the future.
Co-authorship network of co-authors of Andreas Bunge
This figure shows the co-authorship network connecting the top 25 collaborators of Andreas Bunge. A scholar is included among the top collaborators of Andreas Bunge based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Andreas Bunge. Andreas Bunge is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 25 | |
| 2 | 15 | |
| 3 | 5 | |
| 4 | 10 | |
| 5 | 53 | |
| 6 | 120 | |
| 7 | 20 | |
| 8 | 15 | |
| 9 | 50 | |
| 10 | 74 | |
| 11 | 8 | |
| 12 | Anticancer drug sensitivity and expression of multidrug resistance markers in early passage human sarcomas. | 17 |
| 13 | [Morphological and functional features of cytostatic drug resistance and the effects of MDR modulators]. | 1 |
| 14 | 42 | |
| 15 | 16 |
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.